Dr. Krish Patel’s top poster presentations in cellular therapy from SOHO 2026.
CT-1048: Early Mortality Following CAR-T Therapy in Hematologic Malignancies: A Population-Level Study
CT-227: Measurable Residual Disease by Circulating Tumor DNA in Patients With Third-Line or Later Relapsed or Refractory Follicular Lymphoma Treated With Lisocabtagene Maraleucel in TRANSCEND FL
CT-228: Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: First Real-World Data From the Center for International Blood and Marrow Transplant Research
CT-594: Clinical Overview of Infection Events With Orca-T vs Conventional Allogeneic Hematopoietic Stem Cell Transplantation in the Precision-T Phase 3 Study
Krish Patel, MD, is the Director of Lymphoma Research at Sarah Cannon Research Institute in Nashville, Tennessee.
Leave feedback about this